MedaSystems makes it easy for life science companies and health care providers to collaborate to request Expanded Access to experimental therapies. Expanded Access or Compassionate Use (permission to use not-yet-FDA-approved drugs) is a mechanism for severely ill patients desperately searching for a treatment option outside of clinical trials. MedaSystems' cloud-based software offers easy-to-use, scalable tools that automate these complex requests and monitoring processes, offering speed of internal decision-making while capturing real-world evidence and efficient tracking of cases.
We are based in San Francisco, California
and we are hiring for numerous positions including:
To learn more and to apply, go to: